Mykare.ai has raised a total of USD 3.2 million, including an additional USD 1 million in its latest funding round. The round included participation from Andrew and Alfredo, founders of Papa.com, and a leading family office from the Middle East. At a time when investors are pouring billions into AI startups promising to revolutionise healthcare with futuristic technologies, Mykare.ai is focused on a far more fundamental problem: helping clinics and hospitals improve patient access, engagement and overall experience through better operational efficiency. Every day, clinics and hospitals rely on 10+ disconnected systems to manage patient acquisition, appointments, follow-ups, communication, feedback and repetitive admin tasks. To bridge these gaps, healthcare providers often depend on adding more manpower for coordination. At a time when healthcare is already facing a shortage of qualified staff, this creates operational inefficiencies, limits growth, and negatively impacts patient experience. The challenge is especially relevant for small and medium-sized hospitals and clinics globally. Most healthcare organisations globally are clinics and small-to-medium hospitals, and in India, they account for almost 80% of the facilities. These providers serve the majority of patients but continue to struggle with manpower shortages, technology limitations, and resource constraints. As a result, staff spend countless hours switching between systems, coordinating patient journeys, managing follow-ups, and handling administrative tasks instead of focusing on care delivery. The outcome is missed patient opportunities, revenue leakage, delayed follow-ups, and patients slipping through the cracks. Mykare.ai is building an AI-native healthcare operating system that helps clinics and hospitals grow by automating the entire patient journey, from patient acquisition and appointment booking to follow-ups, feedback, and retention. Founded by Senu Sam, Mykare.ai aims to help healthcare providers scale with a single intelligent AI layer that works across fragmented systems. Its AI agents can acquire new patients, identify patient intent, answer calls through voice agents, book appointments, manage follow-ups, collect feedback, and automatically update CRM records, creating a unified patient journey. Mykare has expanded across the United States, the United Kingdom, the Middle East, and India, and currently has a waiting list of more than 20 hospitals and healthcare providers. The new funding will be used to enhance Mykare’s AI capabilities, accelerate product development, and support global expansion.
